Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome - A literature review
Abstract Background Capecitabine (Xeloda®) is a cytotoxic, antimetabolite chemotherapeutic agent. Its most common adverse events are diarrhea, hand-foot syndrome (HFS), hyperbilirubinemia, hyperpigmentation, fatigue, abdominal pain, and other gastrointestinal effects. HFS or palmar-plantar erythrody...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Sociedade Brasileira de Dermatologia,
2023-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|